Useful benefit from Priligy is more than a longer stopwatch result. The treatment should improve the problem that brought you to the consultation while imposing an acceptable burden. Ejaculatory control, distress, satisfaction and unwanted effects all belong in that assessment.

Define the aim before trying to judge success. "I want to feel less rushed and able to pause" gives a clearer starting point than "I want the longest possible encounter." A medicine can increase time without producing the improvement that matters most to the patient.

Start with a baseline that reflects your experience

Describe the usual pattern before treatment: whether ejaculation occurred earlier than wanted on most occasions, how much control you felt and whether the concern caused avoidance or conflict. Approximate timing can be useful without turning every encounter into a measurement exercise.

Also identify erection difficulty separately. If an erection fades before ejaculation, that is relevant to interpreting the treatment. A delay tablet might change ejaculation while leaving the main source of distress unresolved.

The baseline is not a score that you need to perform badly enough to justify care. It is a record against which a meaningful change can be assessed.

Four outcomes worth tracking

OutcomePractical observationPossible interpretation
ControlCan you pause, slow stimulation or feel less rushed?A usable change may exist even without a dramatic time increase
DistressAre you less worried or less likely to avoid intimacy?Continuing worry may need attention beyond delay alone
SatisfactionDoes the experience feel more comfortable and worthwhile?Extra time is not useful if the encounter becomes unpleasant
TolerabilityDo nausea, dizziness or other effects interfere?Benefit may be outweighed by the treatment burden

Controlled dapoxetine trials assessed patient-reported outcomes as well as latency. That broader approach is helpful clinically because a single number cannot describe the whole experience.

Compare patterns, not one unusually good or bad occasion

Benefit can be inconsistent. A dose taken at a different time, a new circumstance or a change in the underlying concern can affect the experience. Note whether the prescribed directions were followed before assuming that the medicine has stopped working or needs a higher strength.

For illustration, a patient might report longer latency but persistent panic about performance. Another might report only a modest time change but a valuable sense of control. These are examples of different outcomes to discuss, not predictions of what treatment will produce.

Avoid interpreting every variation as a pharmacological failure. Equally, do not ignore repeated lack of worthwhile benefit because one occasion went well.

Record the cost of the benefit honestly

Write down unwanted symptoms, including those occurring after sex or interfering with the rest of the day. Nausea, headache and dizziness matter even if the ejaculation outcome was favorable. Feeling close to fainting is particularly important to report.

Do not hide adverse effects because you fear losing a medicine that partly helps. The clinician cannot weigh the prescription properly without knowing both sides of the experience.

A concerning reaction warrants advice before another dose, not a deliberate repeat to collect more diary entries. The assessment of safety is not postponed until a routine follow-up target has been reached.

A short record is enough

  • Approximate tablet timing and whether the prescribed strength was used.
  • Whether the main difficulty occurred and how control differed.
  • Whether erection loss happened before ejaculation.
  • The level of distress and whether the experience was worthwhile.
  • Unwanted symptoms, their severity and effects on everyday function.

You do not need to record every movement or ask a partner to become a stopwatch operator. If tracking makes intimacy more pressured, tell the clinician and use a simpler account.

What can the review decide?

Depending on the findings, the plan may be to continue, clarify administration, reassess a contributing problem, consider a supervised change or stop treatment. A higher dose is only one possible decision and should not be the automatic response to disappointment.

If the medicine improves timing but not control or distress, explain that distinction. If it improves control but causes troublesome effects, the tolerability question still needs resolution. If the diagnosis or treatment target appears wrong, revisiting it is more useful than escalating milligrams.

Success is a repeatable, worthwhile improvement that the patient can use safely. It is not meeting an advertised endurance target, and a good clinical review does not have to end with another prescription to be useful.